Raynaud phenomenon: from GWAS to drug repurposing

Nat Rev Rheumatol. 2024 Mar;20(3):139-140. doi: 10.1038/s41584-024-01076-x.

Authors

Ariane L Herrick¹, Gisela Orozco²

Affiliations

¹ Division of Musculoskeletal and Dermatological Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. ariane.herrick@manchester.ac.uk.
² Division of Musculoskeletal and Dermatological Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.

PMID: 38228855
DOI: 10.1038/s41584-024-01076-x

No abstract available

MeSH terms

Drug Repositioning*
Genome-Wide Association Study
Humans
Raynaud Disease* / drug therapy
Raynaud Disease* / genetics